The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDJAN.L Regulatory News (DJAN)

  • There is currently no data for DJAN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) Daejan Holdings

10 Mar 2020 10:50

RNS Number : 5934F
Nplus1 Singer Capital Markets Ltd
10 March 2020
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Nplus1 Singer Capital Markets Limited

 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

 

Daejan Holdings Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

 

Daejan Holdings Plc

 

(d) Date dealing undertaken:

09 March 2020

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

If YES, specify which:

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD 0.25P

 

 

Purchase

 

9,289

 

7,970p

 

7,960p

 

ORD 0.25P

 

 

Sale

 

9,766

 

8,100p

 

7,970p

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

Date of disclosure:

10 March 2020

Contact name:

Sarah-Rose Perry, Jennifer Bentick, Nick Wright

Telephone number:

020 7496 3093

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FERSFWFSSESSELD
Date   Source Headline
12th Feb 20134:37 pmRNSPrice Monitoring Extension
29th Nov 201210:30 amRNSInterim Results
16th Aug 20127:00 amRNSInterim Management Statement
11th Jul 201210:30 amRNSFinal Results
16th Feb 20121:00 pmRNSInterim Management Statement
30th Nov 201111:31 amRNSInterim Results
17th Aug 201110:55 amRNSInterim Management Statement
13th Jul 201112:30 pmRNSFinal Results
10th Feb 20119:00 amRNSInterim Management Statement
25th Nov 201011:37 amRNSInterim Results
28th Oct 20102:45 pmRNSAnnual Information Update
17th Aug 201011:10 amRNSInterim Management Statement
7th Jul 20102:33 pmRNSFinal Results
28th May 201011:37 amRNSNotification of Transfer
11th Feb 20107:00 amRNSInterim Management Statement
27th Nov 20094:35 pmRNSPrice Monitoring Extension
24th Nov 20093:37 pmRNSDirector/PDMR Shareholding
20th Nov 200912:00 pmRNSInterim Results
30th Sep 20094:35 pmRNSPrice Monitoring Extension
8th Sep 20099:33 amRNSAnnual Information Update
7th Sep 20092:23 pmRNSDirector/PDMR Shareholding
17th Aug 200912:53 pmRNSInterim Management Statement
15th Jul 20093:38 pmRNSPreliminary Results
11th May 20094:40 pmRNSSecond Price Monitoring Extn
11th May 20094:35 pmRNSPrice Monitoring Extension
23rd Apr 20094:35 pmRNSPrice Monitoring Extension
2nd Mar 20094:37 pmRNSPrice Monitoring Extension
13th Feb 20094:40 pmRNSSecond Price Monitoring Extn
13th Feb 20094:35 pmRNSPrice Monitoring Extension
11th Feb 200910:42 amRNSInterim Management Statement
23rd Jan 200911:14 amRNSDirector/PDMR Shareholding
16th Jan 20094:36 pmRNSPrice Monitoring Extension
31st Dec 200812:41 pmRNSSecond Price Monitoring Extn
31st Dec 200812:38 pmRNSPrice Monitoring Extension
26th Nov 200811:59 amRNSInterim Results
21st Nov 20084:49 pmRNSSecond Price Monitoring Extn
21st Nov 20084:40 pmRNSPrice Monitoring Extension
13th Nov 20084:41 pmRNSSecond Price Monitoring Extn
13th Nov 20084:37 pmRNSPrice Monitoring Extension
12th Nov 20084:38 pmRNSPrice Monitoring Extension
4th Nov 20084:37 pmRNSPrice Monitoring Extension
3rd Sep 20087:00 amRNSAnnual Information Update
2nd Sep 20083:57 pmRNSInterim Management Statement
10th Jul 200811:58 amRNSFinal Results
31st Mar 20084:35 pmRNSPrice Monitoring Extension
19th Feb 20084:42 pmRNSInterests in Shares
19th Feb 20084:42 pmRNSTransfer of Shares
19th Feb 20084:35 pmRNSInterests in Shares
11th Feb 200812:47 pmRNSInterim Management Statement
17th Dec 20074:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.